Eupraxia Pharmaceuticals Incの企業情報（従業員数・代表者名など）
企業情報
| 特色 | Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs. The Company’s principal business is the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidate, EP-104IAR, is designed to meet the unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis (OA). The primary active ingredi |
|---|---|
| 英文社名 | Eupraxia Pharmaceuticals Inc |
| 本社所在地 | 201-2067 Cadboro Bay Rd. VICTORIA, BC V8R 5G4 CAN |
| 電話番号 | 250 590-3968 |
| 設立年月 | 2012年1月 |
| 代表者名 | James A. Helliwell |
| 業種名 | 医療関連（Health Care） |
| 市場名 | --- |
| 従業員数 | 29人 |
| ウェブサイト | https://eupraxiapharma.com/home/default.aspx |
